Siemens Healthineers showcases nearly 20 innovative products at the CIIE, with the world's first photon-counting CT-guided PCI solution making its debut

Siemens Healthineers, which launches new products year after year, is once again bringing nearly 20 innovative products and cutting-edge disease solutions to the CIIE! As a "full-attendance" exhibitor, Siemens Healthineers this time focuses on major disease areas such as cardiovascular disease, tumors and neurodegenerative diseases, systematically presenting a series of cutting-edge innovations in fields including imaging diagnostics, interventional therapy, precision radiotherapy and artificial intelligence. Photon-counting CT continues to be refreshed On the Siemens Healthineers booth, the photon-counting CT that has topped the debut charts for consecutive years has new offerings this time: the world's first photon-counting CT-guided PCI solution will make a shining appearance. This solution is currently the world's only PCI (percutaneous coronary intervention) solution guided by photon-counting CT technology. By integrating the revolutionary imaging capabilities of Siemens Healthineers photon-counting CT with the native AI spectral imaging platform of ARTIS genio floor, it addresses the clinical pain points of "can't see clearly, can't judge accurately, difficult to operate" in complex coronary lesions, achieving seamless connectivity from imaging diagnosis to interventional therapy. With the ultra-high spatial resolution of Siemens Healthineers photon-counting CT, physicians can obtain preoperatively a three-dimensional panoramic view of millimeter-level vascular anatomy, plaque composition analysis and stent implantation simulation. This is not just an image, but a "battle map" before entering the catheterization lab, upgrading the prediction of complex lesions from "empirical inference" to "data confirmation." For patients, this solution means more precise diagnosis, lower radiation and higher surgical safety, reducing unnecessary invasive examinations. In addition, the imported photon-counting CT NAEOTOM Alpha.Peak will also appear with a refresh. Building on the continued technical advantages of high spatial resolution, low dose and multi-energy imaging, it newly integrates two fully automatic AI coronary analysis applications, enabling precise assessment of cardiovascular function and intelligent preoperative planning based on native photon-counting CT data, and further connecting to the interventional surgical workflow, driving photon-counting CT to evolve from an advanced imaging tool into an intelligent platform empowering precise coronary diagnosis and treatment. Debuts and first shows are full of AI It is worth mentioning that, judging from the products Siemens Healthineers is debuting and first-showing this year, the "AI content" is quite high. For example, the world's first native AI spectral angiography system ARTIS genio floor will complete its Asian debut and first show at the CIIE. As a new-generation interventional imaging platform from Siemens Healthineers, ARTIS genio floor is equipped with Siemens Healthineers' all-new native AI spectral imaging chain, empowering every key link of the DSA imaging chain with native AI technology, providing more intelligent low-dose imaging support for minimally invasive treatment of complex diseases such as cardiovascular and cerebrovascular diseases and tumors, and helping to improve interventional surgical imaging quality and operational efficiency. In the field of precision radiotherapy, Siemens Healthineers likewise brings a series of revolutionary medical technology innovations. The Halcyon Evolve intelligent ring-shaped individualized radiotherapy platform, making its global debut and first show, achieves comprehensive upgrades in precise treatment, planning efficiency and quality control: the new-generation dual-layer multileaf collimator can automatically optimize for stereotactic radiotherapy and dose falloff at tumor margins, achieving higher dose gradients and increasing the fine conformal capability of radiation beams by 5 times, further improving treatment precision; Eclipse18.1, equipped with a new-generation GPU engine, increases planning speed by more than 50%, comprehensively accelerating and improving the efficiency of clinical planning. At the same time, the all-new MaximQA one-stop refined quality control solution halves quality control time, making quality control more efficient and refined, thereby bringing patients a more precise, efficient and reassuring radiotherapy experience. The BRAVOS individualized brachytherapy solution, making its China debut, extends precision radiotherapy into the interior of tumors, getting closer to patients' individual needs and providing better treatment support for patients with complex gynecological tumors. Unlike external irradiation, brachytherapy delivers the radiation source into or near the tumor, making the radiation act more concentratedly on the tumor. BRAVOS features an innovative quality control system, Monte Carlo-level dose algorithm, finely customized modular combination applicators and a highly integrated treatment workflow, further raising the level of precise brachytherapy. Continuously strengthening local R&D and manufacturing capabilities Siemens Healthineers has six major R&D and manufacturing bases and two global innovation centers in China, with a supply chain localization rate exceeding 80%. In China, Siemens Healthineers focuses on five major aspects: local development, diagnosis and treatment of major diseases, innovation ecosystem, talent cultivation and international exchange, and sustainable development. Through deep local cultivation and comprehensive upgrading, it helps Chinese medical institutions improve clinical diagnosis and treatment levels, operational efficiency and accessibility of high-quality medical services. At the CIIE, as one of Siemens Healthineers' practice cases in promoting localization, the domestically produced photon-counting CT NAEOTOM Alpha.Prime will be prominently displayed. NAEOTOM Alpha.Prime is China's first approved-for-market photon-counting CT with radiotherapy simulation positioning capability. It can not only provide precise imaging diagnosis for radiology departments, but also provide a precise imaging basis for radiotherapy target volume delineation, dose calculation and efficacy evaluation. The high-precision radiotherapy simulation positioning function of NAEOTOM Alpha.Prime, making its Asian debut this time, extends the clinical value of photon-counting CT from diagnosis to the treatment decision-making stage. The device uses the full-spectrum energy information of X-rays to help separate different tissue components and generate quantitative parameter maps reflecting tissue blood perfusion, providing objective imaging evidence for biological functional target volume delineation and dose optimization. This capability enables clinicians to implement more refined dose design for different functional regions, supporting improved precision of tumor irradiation while better protecting key normal tissues. Just this July, Siemens Healthineers announced an investment of more than RMB 100 million to expand its Wuxi R&D and manufacturing base, continuously increasing the layout and investment in local core components. In the future, this multinational giant will continue to strengthen local R&D and manufacturing capabilities, build a more open innovation ecosystem, and help China's medical industry accelerate the realization of high-quality development.